19 January 2017
News and Views
Links and Services
The most recent issue of the Alimentary Pharmacology & Therapeutics examines the individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease.
Infliximab maintenance therapy for Crohn's disease is administered every 8 weeks, but inter-patie
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors